The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dermatology Drugs for Pets Market Research Report 2025

Global Dermatology Drugs for Pets Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1607673

No of Pages : 94

Ask Your Query

Topical (on the body surface) application of medicine can be used to treat specific areas, such as patches of skin, or as a simple way of giving medicine to a patient because some drugs are taken up through the skin into the body.

The global Dermatology Drugs for Pets market was valued at US$ 301 million in 2023 and is anticipated to reach US$ 373.9 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. 

According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 46%.

This report aims to provide a comprehensive presentation of the global market for Dermatology Drugs for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drugs for Pets.

Report Scope

The Dermatology Drugs for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drugs for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dermatology Drugs for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  •  Bayer Animal Health
  •  Boehringer Ingelheim Vetmedica
  •  Ceva Sante Animale
  •  Zoetis Inc.
  •  Elanco
  •  IDEXX Laboratories
  •  Merial
  •  Vetoquinol S.A.panies
  •  Virbac S.A.

By Type

  • Antibiotics
  • Antifungal Drugs
  • Others

By Application

  • Pets Clinics
  • Pets Hospitals
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

 

 

 

 1 Dermatology Drugs for Pets Market Overview
    1.1 Product Overview and Scope of Dermatology Drugs for Pets
    1.2 Dermatology Drugs for Pets Segment by Type
        1.2.1 Global Dermatology Drugs for Pets Market Value Comparison by Type (2024-2030)
        1.2.2 Antibiotics
        1.2.3 Antifungal Drugs
        1.2.4 Others
    1.3 Dermatology Drugs for Pets Segment by Application
        1.3.1 Global Dermatology Drugs for Pets Market Value by Application: (2024-2030)
        1.3.2 Pets Clinics
        1.3.3 Pets Hospitals
        1.3.4 Others
    1.4 Global Dermatology Drugs for Pets Market Size Estimates and Forecasts
        1.4.1 Global Dermatology Drugs for Pets Revenue 2019-2030
        1.4.2 Global Dermatology Drugs for Pets Sales 2019-2030
        1.4.3 Global Dermatology Drugs for Pets Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Dermatology Drugs for Pets Market Competition by Manufacturers
    2.1 Global Dermatology Drugs for Pets Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Dermatology Drugs for Pets Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Dermatology Drugs for Pets Average Price by Manufacturers (2019-2024)
    2.4 Global Dermatology Drugs for Pets Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Dermatology Drugs for Pets, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Dermatology Drugs for Pets, Product Type & Application
    2.7 Dermatology Drugs for Pets Market Competitive Situation and Trends
        2.7.1 Dermatology Drugs for Pets Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Dermatology Drugs for Pets Players Market Share by Revenue
        2.7.3 Global Dermatology Drugs for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Dermatology Drugs for Pets Retrospective Market Scenario by Region
    3.1 Global Dermatology Drugs for Pets Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Dermatology Drugs for Pets Global Dermatology Drugs for Pets Sales by Region: 2019-2030
        3.2.1 Global Dermatology Drugs for Pets Sales by Region: 2019-2024
        3.2.2 Global Dermatology Drugs for Pets Sales by Region: 2025-2030
    3.3 Global Dermatology Drugs for Pets Global Dermatology Drugs for Pets Revenue by Region: 2019-2030
        3.3.1 Global Dermatology Drugs for Pets Revenue by Region: 2019-2024
        3.3.2 Global Dermatology Drugs for Pets Revenue by Region: 2025-2030
    3.4 North America Dermatology Drugs for Pets Market Facts & Figures by Country
        3.4.1 North America Dermatology Drugs for Pets Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Dermatology Drugs for Pets Sales by Country (2019-2030)
        3.4.3 North America Dermatology Drugs for Pets Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Dermatology Drugs for Pets Market Facts & Figures by Country
        3.5.1 Europe Dermatology Drugs for Pets Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Dermatology Drugs for Pets Sales by Country (2019-2030)
        3.5.3 Europe Dermatology Drugs for Pets Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Dermatology Drugs for Pets Market Facts & Figures by Country
        3.6.1 Asia Pacific Dermatology Drugs for Pets Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Dermatology Drugs for Pets Sales by Country (2019-2030)
        3.6.3 Asia Pacific Dermatology Drugs for Pets Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Dermatology Drugs for Pets Market Facts & Figures by Country
        3.7.1 Latin America Dermatology Drugs for Pets Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Dermatology Drugs for Pets Sales by Country (2019-2030)
        3.7.3 Latin America Dermatology Drugs for Pets Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Dermatology Drugs for Pets Market Facts & Figures by Country
        3.8.1 Middle East and Africa Dermatology Drugs for Pets Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Dermatology Drugs for Pets Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Dermatology Drugs for Pets Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Dermatology Drugs for Pets Sales by Type (2019-2030)
        4.1.1 Global Dermatology Drugs for Pets Sales by Type (2019-2024)
        4.1.2 Global Dermatology Drugs for Pets Sales by Type (2025-2030)
        4.1.3 Global Dermatology Drugs for Pets Sales Market Share by Type (2019-2030)
    4.2 Global Dermatology Drugs for Pets Revenue by Type (2019-2030)
        4.2.1 Global Dermatology Drugs for Pets Revenue by Type (2019-2024)
        4.2.2 Global Dermatology Drugs for Pets Revenue by Type (2025-2030)
        4.2.3 Global Dermatology Drugs for Pets Revenue Market Share by Type (2019-2030)
    4.3 Global Dermatology Drugs for Pets Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Dermatology Drugs for Pets Sales by Application (2019-2030)
        5.1.1 Global Dermatology Drugs for Pets Sales by Application (2019-2024)
        5.1.2 Global Dermatology Drugs for Pets Sales by Application (2025-2030)
        5.1.3 Global Dermatology Drugs for Pets Sales Market Share by Application (2019-2030)
    5.2 Global Dermatology Drugs for Pets Revenue by Application (2019-2030)
        5.2.1 Global Dermatology Drugs for Pets Revenue by Application (2019-2024)
        5.2.2 Global Dermatology Drugs for Pets Revenue by Application (2025-2030)
        5.2.3 Global Dermatology Drugs for Pets Revenue Market Share by Application (2019-2030)
    5.3 Global Dermatology Drugs for Pets Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Bayer Animal Health
        6.1.1 Bayer Animal Health Corporation Information
        6.1.2 Bayer Animal Health Description and Business Overview
        6.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Bayer Animal Health Dermatology Drugs for Pets Product Portfolio
        6.1.5 Bayer Animal Health Recent Developments/Updates
    6.2 Boehringer Ingelheim Vetmedica
        6.2.1 Boehringer Ingelheim Vetmedica Corporation Information
        6.2.2 Boehringer Ingelheim Vetmedica Description and Business Overview
        6.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product Portfolio
        6.2.5 Boehringer Ingelheim Vetmedica Recent Developments/Updates
    6.3 Ceva Sante Animale
        6.3.1 Ceva Sante Animale Corporation Information
        6.3.2 Ceva Sante Animale Description and Business Overview
        6.3.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Ceva Sante Animale Dermatology Drugs for Pets Product Portfolio
        6.3.5 Ceva Sante Animale Recent Developments/Updates
    6.4 Zoetis Inc.
        6.4.1 Zoetis Inc. Corporation Information
        6.4.2 Zoetis Inc. Description and Business Overview
        6.4.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Zoetis Inc. Dermatology Drugs for Pets Product Portfolio
        6.4.5 Zoetis Inc. Recent Developments/Updates
    6.5 Elanco
        6.5.1 Elanco Corporation Information
        6.5.2 Elanco Description and Business Overview
        6.5.3 Elanco Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Elanco Dermatology Drugs for Pets Product Portfolio
        6.5.5 Elanco Recent Developments/Updates
    6.6 IDEXX Laboratories
        6.6.1 IDEXX Laboratories Corporation Information
        6.6.2 IDEXX Laboratories Description and Business Overview
        6.6.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 IDEXX Laboratories Dermatology Drugs for Pets Product Portfolio
        6.6.5 IDEXX Laboratories Recent Developments/Updates
    6.7 Merial
        6.6.1 Merial Corporation Information
        6.6.2 Merial Description and Business Overview
        6.6.3 Merial Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Merial Dermatology Drugs for Pets Product Portfolio
        6.7.5 Merial Recent Developments/Updates
    6.8 Vetoquinol S.A.panies
        6.8.1 Vetoquinol S.A.panies Corporation Information
        6.8.2 Vetoquinol S.A.panies Description and Business Overview
        6.8.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Vetoquinol S.A.panies Dermatology Drugs for Pets Product Portfolio
        6.8.5 Vetoquinol S.A.panies Recent Developments/Updates
    6.9 Virbac S.A.
        6.9.1 Virbac S.A. Corporation Information
        6.9.2 Virbac S.A. Description and Business Overview
        6.9.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Virbac S.A. Dermatology Drugs for Pets Product Portfolio
        6.9.5 Virbac S.A. Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Dermatology Drugs for Pets Industry Chain Analysis
    7.2 Dermatology Drugs for Pets Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Dermatology Drugs for Pets Production Mode & Process
    7.4 Dermatology Drugs for Pets Sales and Marketing
        7.4.1 Dermatology Drugs for Pets Sales Channels
        7.4.2 Dermatology Drugs for Pets Distributors
    7.5 Dermatology Drugs for Pets Customers

 8 Dermatology Drugs for Pets Market Dynamics
    8.1 Dermatology Drugs for Pets Industry Trends
    8.2 Dermatology Drugs for Pets Market Drivers
    8.3 Dermatology Drugs for Pets Market Challenges
    8.4 Dermatology Drugs for Pets Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock